Larvol Delta - AdvanCell-to-Present-Promising-Clinical-Trial-Results-of-ADVC001-a-Novel-Lead212based-PSMAtargeted-Alpha-Therapy-for-Prostate-Cancer-at-ESMO-2025

212 Pb-ADVC001 - AdvanCell Isotopes

https://www.businesswire.com/news/home/20251013316172/en/AdvanCell-to-Present-Promising-Clinical-Trial-Results-of-ADVC001-a-Novel-Lead-212-based-PSMA-targeted-Alpha-Therapy-for-Prostate-Cancer-at-ESMO-2025

Oct 12, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next